Search

Your search keyword '"Wang, Yun F."' showing total 219 results
Start Over Author "Wang, Yun F." Publication Year Range Last 50 years Publication Type Periodicals
219 results on '"Wang, Yun F."'

3. Effects of Patient Characteristics on Diagnostic Performance of Self-Collected Samples for SARS-CoV-2 Testing

Author

Smith-Jeffcoat, Sarah E., Koh, Mitsuki, Hoffman, Adam, Rebolledo, Paulina A., Schechter, Marcos C., Miller, Halie K., Sleweon, Sadia, Rossetti, Rebecca, Kasinathan, Vyjayanti, Shragai, Talya, O'Laughlin, Kevin, Espinosa, Catherine C., Khalil, George M., Adeyemo, AdeSubomi O., Moorman, Anne, Bauman, Brenda L., Joseph, Kahaliah, O'Hegarty, Michelle, Kamal, Nazia, Atallah, Hany, Moore, Brooks L., Bohannon, Caitlin D., Bankamp, Bettina, Hartloge, Claire, Bowen, Michael D., Paulick, Ashley, Gargis, Amy S., Elkins, Christopher, Stewart, Rebekah J., da Silva, Juliana, Biedron, Caitlin, Tate, Jacqueline E., Wang, Yun F., and Kirking, Hannah L.

Subjects
Self-examination, Medical -- Methods, Medical testing products -- Usage, Health
Abstract

Detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease (COVID-19), originally relied mainly on nasopharyngeal swab (NPS) samples collected by healthcare workers (HCWs). However, [...]

Published
2021
Full Text
View/download PDF

5. Multidisciplinary assessment of the Abbott BinaxNOW SARS-CoV-2 point-of-care antigen test in the context of emerging viral variants and self-administration

Author

Frediani, Jennifer K., Levy, Joshua M., Rao, Anuradha, Bassit, Leda, Figueroa, Janet, Vos, Miriam B., Wood, Anna, Jerris, Robert, Van Leung-Pineda, Gonzalez, Mark D., Rogers, Beverly B., Mavigner, Maud, Schinazi, Raymond F., Schoof, Nils, Waggoner, Jesse J., Kempker, Russell R., Rebolledo, Paulina A., O’Neal, Jared W., Stone, Cheryl, Chahroudi, Ann, Morris, Claudia R., Suessmith, Allie, Sullivan, Julie, Farmer, Sarah, Foster, Amanda, Roback, John D., Ramachandra, Thanuja, Washington, CaDeidre, Le, Kristie, Cordero, Maria C., Esper, Annette, Nehl, Eric J., Wang, Yun F., Tyburski, Erika A., Martin, Greg S., and Lam, Wilbur A.

Published
2021
Full Text
View/download PDF

6. Evaluation of Xpert MTB/RIF Versus AFB Smear and Culture to Identify Pulmonary Tuberculosis in Patients With Suspected Tuberculosis From Low and Higher Prevalence Settings

Author

Luetkemeyer, Anne F, Firnhaber, Cynthia, Kendall, Michelle A, Wu, Xingye, Mazurek, Gerald H, Benator, Debra A, Arduino, Roberto, Fernandez, Michel, Guy, Elizabeth, Johnson, Pamela, Metchock, Beverly, Sattler, Fred, Telzak, Edward, Wang, Yun F, Weiner, Marc, Swindells, Susan, Sanne, Ian M, Havlir, Diane V, Grinsztejn, Beatriz, and Alland, David

Subjects
Biomedical and Clinical Sciences, Clinical Sciences, Lung, Rare Diseases, Prevention, Biodefense, HIV/AIDS, Clinical Research, Vaccine Related, Infectious Diseases, Tuberculosis, Emerging Infectious Diseases, Detection, screening and diagnosis, 4.2 Evaluation of markers and technologies, Infection, Good Health and Well Being, Adult, Antibiotics, Antitubercular, Brazil, DNA, Bacterial, Drug Resistance, Bacterial, Female, Humans, Male, Middle Aged, Mutation, Mycobacterium tuberculosis, Nucleic Acid Amplification Techniques, Prevalence, Rifampin, Sensitivity and Specificity, South Africa, Sputum, Tuberculosis, Pulmonary, United States, Xpert MTB/RIF, tuberculosis diagnosis, respiratory isolation, nontuberculous mycobacteria, HIV/tuberculosis coinfection, AIDS Clinical Trials Group A5295 and Tuberculosis Trials Consortium Study 34 Teams, Biological Sciences, Medical and Health Sciences, Microbiology, Clinical sciences
Abstract

BackgroundThe Xpert MTB/RIF (Xpert) assay is a rapid nucleic acid amplification test widely used in settings of high tuberculosis prevalence to detect tuberculosis as well asrpoBmutations associated with rifampin resistance. Data are needed on the diagnostic performance of Xpert in lower-prevalence settings to inform appropriate use for both tuberculosis detection and the need for respiratory isolation.MethodsXpert was compared to 2 sputum samples, each evaluated with acid-fast bacilli (AFB) smear and mycobacterial culture using liquid and solid culture media, from participants with suspected pulmonary tuberculosis from the United States, Brazil, and South Africa.ResultsOf 992 participants enrolled with evaluable results, 22% had culture-confirmed tuberculosis. In 638 (64%) US participants, 1 Xpert result demonstrated sensitivity of 85.2% (96.7% in participants with AFB smear-positive [AFB(+)] sputum, 59.3% with AFB smear-negative [AFB(-)] sputum), specificity of 99.2%, negative predictive value (NPV) of 97.6%, and positive predictive value of 94.9%. Results did not differ between higher- and low-prevalence settings. A second Xpert assay increased overall sensitivity to 91.1% (100% if AFB(+), 71.4% if AFB(-)), with specificity of 98.9%. In US participants, a single negative Xpert result predicted the absence of AFB(+)/culture-positive tuberculosis with an NPV of 99.7%; NPV of 2 Xpert assays was 100%, suggesting a role in removing patients from airborne infection isolation. Xpert detected tuberculosis DNA and mutations associated with rifampin resistance in 5 of 7 participants with rifampin-resistant, culture-positive tuberculosis. Specificity for rifampin resistance was 99.5% and NPV was 98.9%.ConclusionsIn the United States, Xpert testing performed comparably to 2 higher-tuberculosis-prevalence settings. These data support the use of Xpert in the initial evaluation of tuberculosis suspects and in algorithms assessing need for respiratory isolation.

Published
2016

10. Utility of a Viral Vesicular Panel Multiplex Polymerase Chain Reaction Assay for the Diagnosis of Monkeypox, Herpes Simplex, and Varicella Zoster Viruses

Author

Wilber, Eli, primary, Rebolledo, Paulina A, additional, Kasinathan, Vyjayanti, additional, Merritt, Stephanie, additional, Titanji, Boghuma K, additional, Aldred, Bruce, additional, Kandiah, Sheetal, additional, Ray, Susan M, additional, Sheth, Anandi N, additional, Colasanti, Jonathan A, additional, and Wang, Yun F, additional

Published
2023
Full Text
View/download PDF

11. Severe Acute Respiratory Syndrome Coronavirus 2 Evolution and Escape From Combination Monoclonal Antibody Treatment in a Person With HIV

Author

Khosravi, Dara, primary, Soloff, Hannah, additional, Langsjoen, Rose M, additional, Bombin, Andrei, additional, Kelley, Colleen F, additional, Ray, Susan M, additional, Gunthel, Clifford J, additional, Zanoni, Brian C, additional, Nguyen, Phuong-Vi, additional, Waggoner, Jesse J, additional, Wang, Yun F, additional, Cantos, Valeria D, additional, and Piantadosi, Anne, additional

Published
2023
Full Text
View/download PDF

13. Evaluation of Xpert MTB/RIF Versus AFB Smear and Culture to Identify Pulmonary Tuberculosis in Patients With Suspected Tuberculosis From Low and Higher Prevalence Settings

Author

AIDS Clinical Trials Group A5295 and Tuberculosis Trials Consortium Study 34 Teams, Luetkemeyer, Anne F., Firnhaber, Cynthia, Kendall, Michelle A., Wu, Xingye, Mazurek, Gerald H., Benator, Debra A., Arduino, Roberto, Fernandez, Michel, Guy, Elizabeth, Johnson, Pamela, Metchock, Beverly, Sattler, Fred, Telzak, Edward, Wang, Yun F., Weiner, Marc, Swindells, Susan, Sanne, Ian M., Havlir, Diane V., Grinsztejn, Beatriz, and Alland, David

Published
2016

15. High Mortality among Older Patients Hospitalized with COVID-19 during the First Pandemic Wave

Author

Kempker, Russell R, primary, Rebolledo, Paulina Alejandra, additional, Rollin, Francois, additional, Gurbani, Saumya, additional, Schechter, Marcos C, additional, Wilhoite, David A, additional, Bogard, Sherri N, additional, Watkins, Stacey, additional, Duggal, Aarti, additional, John, Nova, additional, Kapuria, Malavika, additional, Terry, Charles, additional, Yang, Philip, additional, Dale, Gordon, additional, Mora, Ariana, additional, Preslar, Jessica, additional, Sandor, Katilin, additional, Wang, Yun F, additional, Woodworth, Michael H, additional, and Kempker, Jordan A, additional

Published
2022
Full Text
View/download PDF

19. A critical challenge: Dosage-related efficacy and acute complication intracoronary injection of autologous bone marrow mesenchymal stem cells in acute myocardial infarction

Author

Gao, Lian R., Pei, Xue T., Ding, Qing A., Chen, Yu, Zhang, Ning K., Chen, Hai Y., Wang, Zhi G., Wang, Yun F., Zhu, Zhi M., Li, Tian C., Liu, Hui L., Tong, Zi C., Yang, Yong, Nan, Xue, Guo, Feng, Shen, Jian L., Shen, Yan H., Zhang, Jian J., Fei, Yu X., Xu, Hong T., Wang, Li H., Tian, Hai T., Liu, Da Q., and Yang, Ye

Published
2013
Full Text
View/download PDF

21. Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response

Author

Adekambi, Toidi, Ibegbu, Chris C., Cagle, Stephanie, Kalokhe, Ameeta S., Wang, Yun F., Hu, Yijuan, Day, Cheryl L., Ray, Susan M., and Rengarajan, Jyothi

Subjects
Tuberculosis -- Health aspects -- Drug therapy -- Diagnosis -- Research, T cells -- Health aspects -- Physiological aspects -- Research, Biological markers -- Health aspects -- Physiological aspects -- Research, Health care industry
Abstract

BACKGROUND. The identification and treatment of individuals with tuberculosis (TB) is a global public health priority. Accurate diagnosis of pulmonary active TB (ATB) disease remains challenging and relies on extensive medical evaluation and detection of Mycobacterium tuberculosis (Mtb) in the patient's sputum. Further, the response to treatment is monitored by sputum culture conversion, which takes several weeks for results. Here, we sought to identify blood-based host biomarkers associated with ATB and hypothesized that immune activation markers on Mtb-specific [CD4.sup.+] T cells would be associated with Mtb load in vivo and could thus provide a gauge of Mtb infection. METHODS. Using polychromatic flow cytometry, we evaluated the expression of immune activation markers on Mtb-specific [CD4.sup.+] T cells from individuals with asymptomatic latent Mtb infection (LTBI) and ATB as well as from ATB patients undergoing anti-TB treatment. RESULTS. Frequencies of Mtb-specific IFN-[[gamma].sup.+][CD4.sup.+] T cells that expressed immune activation markers CD38 and HLA-DR as well as intracellular proliferation marker Ki-67 were substantially higher in subjects with ATB compared with those with LTBI. These markers accurately classified ATB and LTBI status, with cutoff values of 18%, 60%, and 5% for [CD38.sup.+]IFN-[[gamma].sup.+], [HLA-DR.sup.+]IFN-[[gamma].sup.+], and [Ki-67.sup.+]IFN-[[gamma].sup.+], respectively, with 100% specificity and greater than 96% sensitivity. These markers also distinguished individuals with untreated ATB from those who had successfully completed anti-TB treatment and correlated with decreasing mycobacterial loads during treatment. CONCLUSION. We have identified host blood-based biomarkers on Mtb-specific [CD4.sup.+] T cells that discriminate between ATB and LTBI and provide a set of tools for monitoring treatment response and cure. TRIAL REGISTRATION. Registration is not required for observational studies. FUNDING. This study was funded by Emory University, the NIH, and the Yerkes National Primate Center., Introduction Diagnosis of pulmonary active tuberculosis (ATB) currently relies on evaluation of clinical symptoms, radiological assessments, and detection of Mycobacterium tuberculosis (Mtb) in patient respiratory samples, such as sputum. Microscopic [...]

Published
2015
Full Text
View/download PDF

23. Outbreak of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) in hospitalized hemodialysis patients: An epidemiologic and genomic investigation

Author

Marvil, Charles E., primary, Babiker, Ahmed, additional, Preston, Aaron, additional, Webster, Andrew S., additional, Guarner, Jeannette, additional, Love, Kari, additional, Ghonim, Elham, additional, Rebolledo, Paulina A., additional, Wang, Yun F., additional, Arthur, Robert A., additional, Johnston, H. Richard, additional, Waggoner, Jesse J., additional, Piantadosi, Anne, additional, and Jacob, Jesse T., additional

Published
2021
Full Text
View/download PDF

24. Diagnosis of Streptococcus pneumoniae infection using circulating antibody secreting cells

Author

Kyu, Shuya, primary, Ramonell, Richard P., additional, Kuruvilla, Merin, additional, Kraft, Colleen S., additional, Wang, Yun F., additional, Falsey, Ann R., additional, Walsh, Edward E., additional, Daiss, John L., additional, Paulos, Simon, additional, Rajam, Gowrisankar, additional, Wu, Hao, additional, Velusamy, Srinivasan, additional, and Lee, F. Eun-Hyung, additional

Published
2021
Full Text
View/download PDF

28. The need for new test verification and regulatory support for innovative diagnostics

Author

Roback, John D., primary, Tyburski, Erika A., additional, Alter, David, additional, Asakrah, Saja, additional, Chahroudi, Ann, additional, Esper, Annette, additional, Farmer, Sarah, additional, Figueroa, Janet, additional, K. Frediani, Jennifer, additional, D. Gonzalez, Mark, additional, S. Gottfried, David, additional, Guarner, Jeannette, additional, A. Gupta, Nitika, additional, S. Heilman, Stacy, additional, E. Hill, Charles, additional, Jerris, Robert, additional, R. Kempker, Russell, additional, Ingersoll, Jessica, additional, Levy, Joshua M., additional, Mavigner, Maud, additional, S. Moreno, Carlos, additional, R. Morris, Claudia, additional, J. Nehl, Eric, additional, S. Neish, Andrew, additional, Peker, Deniz, additional, Saakadze, Natia, additional, Rebolledo, Paulina A., additional, A. Rostad, Christina, additional, Schoof, Nils, additional, Suessmith, Allie, additional, Sullivan, Julie, additional, Wang, Yun F., additional, Wood, Anna, additional, Vos, Miriam B., additional, Brand, Oliver, additional, Martin, Greg S., additional, and Lam, Wilbur A., additional

Published
2021
Full Text
View/download PDF

33. Specimen self-collection for SARS-CoV-2 testing: Patient performance and preferences—Atlanta, Georgia, August-October 2020.

Author

O'Laughlin, Kevin, Espinosa, Catherine C., Smith-Jeffcoat, Sarah E., Koh, Mitsuki, Khalil, George M., Hoffman, Adam, Rebolledo, Paulina A., Schechter, Marcos C., Stewart, Rebekah J., da Silva, Juliana, Biedron, Caitlin, Bankamp, Bettina, Folster, Jennifer, Gargis, Amy S., Bowen, Michael D., Paulick, Ashley, Wang, Yun F., Tate, Jacqueline E., and Kirking, Hannah L.

Subjects
COVID-19 testing, PATIENT preferences, MEDICAL personnel, SELF-efficacy, SALIVA
Abstract

Self-collected specimens can expand access to SARS-CoV-2 testing. At a large inner-city hospital 1,082 participants self-collected saliva and anterior nasal swab (ANS) samples before healthcare workers collected nasopharyngeal swab (NPS) samples on the same day. To characterize patient preferences for self-collection, this investigation explored ability, comfort, and ease of ANS and saliva self-collection for SARS-CoV-2 testing along with associated patient characteristics, including medical history and symptoms of COVID-19. With nearly all participants successfully submitting a specimen, favorable ratings from most participants (at least >79% in ease and comfort), and equivocal preference between saliva and ANS, self-collection is a viable SARS-CoV-2 testing option. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

34. The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change

Author

Nehl, Eric, primary, Heilman, Stacy, additional, Ku, David, additional, Gottfried, David, additional, Farmer, Sarah, additional, Mannino, Robert, additional, Tyburski, Erika, additional, Sullivan, Julie, additional, Suessmith, Allison, additional, Bassit, Leda, additional, Figueroa, Janet, additional, Wood, Anna, additional, Leong, Traci, additional, Rao, Anuradha, additional, Rogers, Beverly, additional, Jerris, Robert, additional, Park, Sunita, additional, Gonzalez, Mark, additional, Frediani, Jennifer, additional, Morris, Claudia, additional, Levy, Joshua, additional, Schoof, Nils, additional, Mavigner, Maud, additional, Roback, John, additional, Herzegh, Kristen, additional, Saakadze, Natia, additional, Ingersoll, Jess, additional, Cheedarla, Narayana, additional, Neish, Andrew, additional, Hanberry, Bradley, additional, Porter, Christopher, additional, Esper, Annette, additional, Kempker, Russell, additional, Rebolledo, Paulina, additional, McGuinness, Pamela, additional, Balagadde, Frederick, additional, Gore, Rebecca, additional, Koren, Ainat, additional, Pollock, Nira, additional, Rogers, Eugene, additional, Simin, Karl, additional, Hafer, Nathaniel, additional, Picard, Mary Ann, additional, Ghezzi, Chiara, additional, McManus, David, additional, Buchholz, Bryan, additional, Rostad, Christina, additional, Claveria, Viviana, additional, Ramachandra, Thanuja, additional, Wang, Yun F., additional, Washington, CaDeidre, additional, Stone, Cheryl, additional, Griffiths, Mark, additional, Schinazi, Ray, additional, Chahroudi, Ann, additional, Vos, Miriam, additional, Brand, Oliver, additional, Martin, Greg, additional, and Lam, Wilbur, additional

Published
2021
Full Text
View/download PDF

35. Covid‐19 will not “magically disappear”: Why access to widespread testing is paramount

Author

George, Paul E., primary, Stokes, Claire L., additional, Bassit, Leda C., additional, Chahroudi, Ann, additional, Figueroa, Janet, additional, Griffiths, Mark A., additional, Heilman, Stacy, additional, Ku, David N., additional, Nehl, Eric J., additional, Leong, Traci, additional, Levy, Joshua M., additional, Kempker, Russell R., additional, Mannino, Robert G., additional, Mavigner, Maud, additional, Park, Sunita I., additional, Rao, Anuradha, additional, Rebolledo, Paulina A., additional, Roback, John D., additional, Rogers, Beverly B., additional, Schinazi, Raymond F., additional, Suessmith, Allie B., additional, Sullivan, Julie, additional, Tyburski, Erika A., additional, Vos, Miriam B., additional, Waggoner, Jesse J., additional, Wang, Yun F. (Wayne), additional, Madsen, Jen, additional, Wechsler, Daniel S., additional, Joiner, Clinton H., additional, Martin, Greg S., additional, and Lam, Wilbur A., additional

Published
2020
Full Text
View/download PDF

38. Outbreak of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) in hospitalized hemodialysis patients: An epidemiologic and genomic investigation

Author

Marvil, Charles E., Babiker, Ahmed, Preston, Aaron, Webster, Andrew S., Guarner, Jeannette, Love, Kari, Ghonim, Elham, Rebolledo, Paulina A., Wang, Yun F., Arthur, Robert A., Johnston, H. Richard, Waggoner, Jesse J., Piantadosi, Anne, and Jacob, Jesse T.

Abstract

AbstractWe performed an epidemiological investigation and genome sequencing of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) to define the source and scope of an outbreak in a cluster of hospitalized patients. Lack of appropriate respiratory hygiene led to SARS-CoV-2 transmission to patients and healthcare workers during a single hemodialysis session, highlighting the importance of infection prevention precautions.

Published
2023
Full Text
View/download PDF

41. Routine HIV Test Results in 6 US Clinical Laboratories Using the Recommended Laboratory HIV Testing Algorithm With Geenius HIV 1/2 Supplemental Assay

Author

Wesolowski, Laura G., primary, Chavez, Pollyanna R., additional, Cárdenas, Ana María, additional, Katayev, Alex, additional, Slev, Patricia, additional, Valsamakis, Alexandra, additional, Wang, Yun F., additional, Yao, Joseph D., additional, Dougherty, Caitlin, additional, Gillim-Ross, Laura, additional, Harmon, Christopher, additional, and Delaney, Kevin P., additional

Published
2020
Full Text
View/download PDF

44. Discordance in Mycobacterium tuberculosis rifampin susceptibility

Author

Kalokhe, Ameeta S., Shafiq, Majid, Lee, James C., Metchock, Beverly, Posey, James E., Ray, Susan M., Anderson, Albert, Wang, Yun F., and Nguyen, Minh Ly T.

Subjects
Drug resistance in microorganisms -- Research, Rifampin -- Health aspects -- Research, Tuberculosis -- Drug therapy -- Research, Health
Abstract

To the Editor: Multidrug-resistant tuberculosis (MDR TB), i.e., TB resistant to at least the 2 most effective first-line antituberculous drugs (isoniazid [INH] and rifampin [RIF]), is increasing globally. World Health [...]

Published
2012
Full Text
View/download PDF

46. Treatment Complexities Among Patients with Tuberculosis in a High HIV Prevalence Cohort in the United States

Author

Bizune, Destani J., primary, Kempker, Russell R., additional, Kagei, Michelle, additional, Yamin, Aliya, additional, Mohamed, Omar, additional, Holland, David P., additional, Oladele, Alawode, additional, Wang, Yun F., additional, Rebolledo, Paulina A., additional, Blumberg, Henry M., additional, Ray, Susan M., additional, and Schechter, Marcos C., additional

Published
2018
Full Text
View/download PDF

47. Functional–structural relationship in large‐scale brain networks of patients with end stage renal disease after kidney transplantation: A longitudinal study.

Author

Chen, Hui J., Wang, Yun F., Wen, Jiqiu, Xu, Qiang, Lu, Guang M., and Zhang, Long J.

Subjects
*CHRONIC kidney failure, *KIDNEY transplantation, *DIFFUSION tensor imaging, *FUNCTIONAL magnetic resonance imaging, *KIDNEY diseases, *LARGE-scale brain networks
Abstract

It is unclear how the brain network changed after kidney transplantation (KT). We explored the patterns of large‐scale complex network after KT in end‐stage renal disease (ESRD) patients with resting‐state functional MRI (rs‐fMRI) and diffusion tensor imaging (DTI). Twenty‐one ESRD patients (14 men; mean age, 31.5 ± 9.9 years) scheduled for KT and 17 age‐ and gender‐matched healthy controls (HC) (8 men; mean age, 28.9 ± 7.2 years) were enrolled in this study. Each participant underwent rs‐fMRI and DTI scans in three time points (pre‐KT, 1 and 6 months after KT [for ESRD]). Graph theory analysis was used to characterize the topological properties by using functional and structural network connectivities intergroup correlation analysis was performed between functional/structural MR indexes and clinical markers. Compared with HC, pre‐KT ESRD patients showed an altered topological organization in both functional and structural networks. Compared with pre‐KT, increased node degree and node efficiency were observed for both functional and structural networks at 1 month after KT (all p <.05), which were further increased at 6 months after KT (p <.05). Both functional and structural networks did not recover completely at 6 months after KT (all p <.05). The patients showed an increased functional–structural connectivity coupling at 1 month after KT compared with HC (p =.041). A trend of progressive recovery of functional and structural connectivity networks was observed in ERSD patients after KT, which did not recover to the normal levels even in 6 months after KT. The study results underlie cognitive function recovery in ESRD patients following KT in the neuropathophysiological perspective. [ABSTRACT FROM AUTHOR]

Published
2020
Full Text
View/download PDF

50. Loss of Smell and Taste Among Healthcare Personnel Screened for Coronavirus 2019.

Author

Kempker, Russell R, Kempker, Jordan A, Peters, Marcia, Rebolledo, Paulina A, Carroll, Kelley, Toomer, Linda, Wang, Yun F (Wayne), Ray, Susan M, and Hunter, Mary

Subjects
COVID-19, AGEUSIA, SICK people, MEDICAL personnel, MEDICAL screening, SMELL disorders, SYMPTOMS, DESCRIPTIVE statistics
Abstract

Among 283 symptomatic healthcare personnel (HCP) tested for SARS-CoV-2, 51 (18%) were positive. Among those 51 HCP, self reported loss of smell and taste were present in 51% and 52.9%, respectively, with either present in 60.8%. These symptoms had high specificity (93% each, 96% for either) for a positive SARS-CoV-2 test. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results